-
2107-2021
WHO continues fight against pandemic amid worsening global public health emergency and uneven vaccine rollout
"We are experiencing a worsening public health emergency that further threatens lives, livelihoods and a sound global economic recovery. It is definitely worse in places that have very few vaccines, but the pandemic is not over anywhere", said WHO Director-General Tedros Adhanom Ghebreyesus at a WHO media briefing this week.
-
0707-2021
WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access
The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids.
-
0207-2021
Billions of people will lack access to safe water, sanitation and hygiene in 2030 unless progress quadruples – warn WHO, UNICEF
Billions of people around the world will be unable to access safely managed household drinking water, sanitation and hygiene services in 2030 unless the rate of progress quadruples, according to a new report from WHO and UNICEF
-
2506-2021
Directors General of WHO, WIPO and the WTO agree on intensified cooperation in support of access tackle the COVID-19 pandemic
Directors General of WHO, WIPO and the WTO agree on intensified cooperation in support of access tackle the COVID-19 pandemic。
-
2406-2021
UNESCO and WHO urge countries to make every school a health-promoting school
UNESCO and the World Health Organization today launched the Global Standards for Health-promoting Schools, a resource package for schools to improve the health and well-being of 1.9 billion school-aged children and adolescents. The closure of many schools around the world during the COVID-19 pandemic has caused severe disruptions to education. An estimated 365 million primary school students went without school meals and significantly increased rates of stress, anxiety and other mental health issues.
-
2206-2021
WHO supporting South African consortium to establish first COVID mRNA vaccine technology transfer hub
Geneva/Johannesburg/Paris: The World Health Organization (WHO) and its COVAX partners are working with a South African consortium comprising Biovac, Afrigen Biologics and Vaccines, a network of universities and the Africa Centres for Disease Control and Prevention (CDC) to establish its first COVID mRNA vaccine technology transfer hub.
-
0206-2021
WHO validates Sinovac COVID-19 vaccine for emergency use and issues interim policy recommendations
WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it meets international standards for safety, efficacy and manufacturing. The vaccine is produced by the Beijing-based pharmaceutical company Sinovac.
-
2505-2021
WHO and Switzerland launch global BioHub for pathogen storage, sharing and analysis
The World Health Organization (WHO) and the Swiss Confederation today signed a Memorandum of Understanding to launch the first WHO BioHub Facility as part of the WHO BioHub System, which was announced in November 2020. This facility will enhance the rapid sharing of viruses and other pathogens between laboratories and partners globally.
-
1205-2021
WHO’s work in all regions remains critical in the ongoing fight against COVID-19
As COVID-19 surges around the world, WHO continues its efforts to tackle the ongoing pandemic. Beyond the frontpage headlines, WHO with its partners' and donors' support, keeps working to help countries prevent, test for and treat the virus.
-
0805-2021
WHO lists additional COVID-19 vaccine for emergency use and issues interim policy recommendations
WHO today listed the Sinopharm COVID-19 vaccine for emergency use, giving the green light for this vaccine to be rolled out globally. The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).